![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.025 | 1.56% | 1.625 | 1.60 | 1.65 | 1.675 | 1.60 | 1.60 | 11,401,604 | 10:40:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -0.36 | 1.87M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/5/2024 17:58 | A company called Sareum has recently raised funds by way of placing at 10 p. Soon after the share price went through 30 p. | ![]() kingston78 | |
09/5/2024 17:24 | dulution! a new one one on me! | ![]() abbynat | |
09/5/2024 17:00 | Wth 1.5p placing!!!!Dulution | ![]() neo26 | |
09/5/2024 16:57 | They've been working on it for weeks with a target raise of £6m. You'll see from the RNS that they've only got £2.5m for sure and are hoping that they'll get the balance of £3.5m via REX, which I think will be challenging. It's unclear what will happen if they don't get the full £6m as everything is conditional on a minimum of £6m being raised! | ![]() jaknife | |
09/5/2024 16:54 | 57% discount - Blimey | ![]() thecroots | |
09/5/2024 16:49 | ^^ Here you go suckers. Fund raise at 1.5p a share. | ![]() jaknife | |
09/5/2024 16:34 | Oh get over yourself . How's Ocado doing? | ![]() hazl | |
09/5/2024 15:54 | Dead in the water now, dead cat bounce caught a lot out. Biological pish Muppets bought doh🤦🏻 | ![]() ny boy | |
09/5/2024 14:48 | Now let's just concentrate on the company. They have a virtual conference coming up. They have NICE result expected in the summer. The new partnership with the US company. Surely, they must have some idea of cash coming in or they wouldn't be pursing these things I would have thought. We will see in time. IMO | ![]() hazl | |
09/5/2024 14:44 | So they seek to discredit others whilst they have what appears to me a far worse record. We can both play the same childish game you see? | ![]() hazl | |
09/5/2024 14:42 | Millenialinvestor . 'Says the person who paid 300p for BOO apparently, now it is 34.46p?. 'millennialinvestor 9 Feb '24 - 12:28 - 98628 of 98631 0 0 0 boo day as we wait for 40p easily.' | ![]() hazl | |
09/5/2024 14:36 | Anyone would think you believe you're a guru HC? Oops seems not this is now well down. 'Hooded Claw 7 Apr '22 - 09:57 - 3391 of 3626 0 1 0 Wow what timing. I bought almost £9k at 18.18p this morning'. | ![]() hazl | |
09/5/2024 14:17 | hazl4 Apr '24 - 12:28 - 3320 of 3722 0 1 0 There are real reasons for the rise and it started before the announcement. Thank goodness reality has set in at last. This company deserves so much better. Nice to see hazl desperate on another share. lol. She does pick absolute dogs. | ![]() millennialinvestor | |
09/5/2024 13:32 | The Stroke Association estimates that yearly hospital admissions for stroke could rise to 151,000 by 2035. | ![]() hazl | |
09/5/2024 13:27 | genedrive plc @genedriveplc Join us online NEXT WEEK for the POCT-for-Scot virtual conference! Professor Bill Newman will be speaking on the Genedrive MT-RNR1 ID Kit at 1:30pm. We hope to see you there! | ![]() hazl | |
09/5/2024 11:00 | The contrast in this company's volatile share price! Down 20% in the last month down over 50 since January . YET A month ago. 'Genedrive shares surge as UK's NICE backs test for ischaemic stroke '. And 'AIM - WINNERS ---------- Genedrive PLC, up 57% at 5.90 pence, 12-month range 2.56p-34.90p. The molecular diagnostics company announces that the UK's National Institute for Health & Care Excellence has recommended in draft guidance that Genedrive's CYP2C19-ID test should be used as the point-of-care test of choice for ischemic stroke and transient ischaemic attack patients.' Yet they need someone to back them financially. Crazy. Is that board member with a strength in mergers and acquistions, hoping to put this company's fortunes in the pockets of someoe else at a fraction of the price it deserves, I wonder? Am I being unfair? Possibly. I wonder why he doesn't provide a bit of cash himself? Just thoughts nothing else. | ![]() hazl | |
09/5/2024 10:24 | I NEVER tell people to buy. FACT. | ![]() hazl | |
09/5/2024 09:58 | You were telling people to buy and said I was lying about needing to raise funds as they already had done. So yes, you lied. | hooded claw | |
09/5/2024 09:22 | Goodness I have just been alerted to this. | ![]() hazl | |
09/5/2024 09:11 | I will tell you what gets me. Here is an article about children that are born deaf. Where the emphasis is given to a company with complicated gene editing presumably. Yet in contrast GDR provide a simple test to children who do not have a hearing problem to attempt to prevent them from losing one of their senses by the hospital, inadvertently giving the WRONG treatment, because of time restraints! Our tests speed the assessment up.It is as simple as that! Why haven't we been having our praises sung? Because the big companies didn't think of it first is my theory. If this is just down to money and delay it is shocking in my opinion. I will add that the hospital are doing their best as these are sick children who need an antibiotic and fast. IMO | ![]() hazl |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions